Ovoca Bio (OVB:LSE) Investor Relations Material

Overview

Ovoca Bio is a biopharmaceutical company that specializes in women's health, particularly in the development of a novel treatment for women with hypoactive sexual desire disorder (HSDD). This condition affects approximately one in ten premenopausal women and is characterized by a lack or loss of sexual desire. With a focus on addressing this widespread issue, Ovoca Bio is a promising clinical-stage company poised to make a major impact in the field of women's health.

Frequently Asked Questions

What is Ovoca Bio's ticker?

Ovoca Bio's ticker is OVB

What exchange is Ovoca Bio traded on?

The company's shares trade on the LSE stock exchange

Where are Ovoca Bio's headquarters?

They are based in Dublin, Republic of Ireland

How many employees does Ovoca Bio have?

There are 1-10 employees working at Ovoca Bio

What is Ovoca Bio's website?

It is https://ovocabio.com/

What type of sector is Ovoca Bio?

Ovoca Bio is in the Healthcare sector

What type of industry is Ovoca Bio?

Ovoca Bio is in the Biotechnology industry

Who are Ovoca Bio's peers and competitors?

The following five companies are Ovoca Bio's industry peers:

- Unity Biotechnology, Inc.

- Portola Pharmaceuticals

- Intercept Pharmaceuticals

- BridgeBio Pharma

- Nuvo Pharmaceuticals, Inc.